StockData
Elanco Animal Health Inc logo

Elanco Animal Health Inc (ELAN) stock

ELANNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 9/30129% above fair value
$25.85−0.56 (-2.12%)

Close on Nov 17, 2026Market cap $12.92BP/E –Yield –

Elanco Animal Health price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Elanco Animal Health's price to sales ratio was 2.6× on Nov 11, 2026, against 2.5× a year earlier. Over the last 5 years it ranged from 0.9× to 2.8×, with a median of 1.7×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20262.6×+0.2
2025Dec 31, 20252.4×+1.1
2024Dec 31, 20241.3×−0.3
2023Dec 29, 20231.7×+0.4
2022Dec 30, 20221.3×−1.5
2021Dec 31, 20212.8×−2.2
2020Dec 31, 20205.0×+1.4
2019Dec 31, 20193.6×−0.3
2018Dec 31, 20183.8×–

More Elanco Animal Health figures

See a number that looks wrong?